PRESS RELEASE
Apr 22, 2024
Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical Materials Needed, Matches Classical Wet Lab Binning Results
Apr 12, 2024
ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments
Mar 08, 2024
ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology
Feb 13, 2024
ImmunoPrecise Antibodies (NASDAQ:IPA) Is Changing How We Look At The Complex World Of Antibody Discovery
Jan 10, 2024
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms
Dec 07, 2023
ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14
Nov 22, 2023
ImmunoPrecise's BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery
Oct 20, 2023
Overcoming the Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data
Oct 13, 2023
How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research
Aug 31, 2020
LD Micro -- 360 Companies Set to Present this Week